CFDB - Cystic Fibrosis DataBase

All subcategories » published, non RCT

The long-term effects of insulin use in incident cystic fibrosis-related diabetes: a target trial emulated using longitudinal national registry data.

primary studies  published, non RCT

Details
  • 2022
  • Granger E

Feasibility and acceptability of a CF-specific cognitive-behavioral preventive intervention for adults integrated into team-based care.

primary studies  published, non RCT

Details
  • 2022
  • Friedman D

Health care costs in a randomized trial of antimicrobial duration among cystic fibrosis patients with pulmonary exacerbations.

primary studies  published, non RCT

Details
  • 2022
  • Gold LS

Impact of pharmacy services on time to elexacaftor-tezacaftor-ivacaftor initiation.

primary studies  published, non RCT

Details
  • 2022
  • Roder L

Feasibility and efficacy of combined pancreatic islet-lung transplantation in cystic fibrosis related diabetes -PIM study: a multicenter phase 1-2 trial.

primary studies  published, non RCT

Details
  • 2022
  • Rakotoarisoa L

The Effect of Control IQ Hybrid Closed Loop Technology on Glycemic Control in Adolescents and Adults with Cystic Fibrosis-Related Diabetes.

primary studies  published, non RCT

Details
  • 2022
  • Scully KJ

The Short Term Influence of Chest Physiotherapy on Lung Function Parameters in Children With Cystic Fibrosis and Primary Ciliary Dyskinesia.

primary studies  published, non RCT

Details
  • 2022
  • Vandervoort B

The Role of Bronchoscopy in the Management of Children With Cystic Fibrosis.

primary studies  published, non RCT

Details
  • 2022
  • Tosco A

Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactation.

primary studies  published, non RCT

Details
  • 2021
  • Taylor-Cousar JL

Lumacaftor/ivacaftor in cystic fibrosis: effects on glucose metabolism and insulin secretion.

primary studies  published, non RCT

Details
  • 2021
  • Colombo C